Parkinson's disease belongs to a group of conditions called movement disorders. It is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions. It affects around 13 million people worldwide. This program follows a group of patients as they test a promising new drug meant to slow the progression of the disease. Featuring leading neurologists and professors, it explains the science behind the trial and traces the volunteers' experiences over the period of a year. An enlightening program that answers many of the questions surrounding Parkinson's Disease.